已發(fā)表的部分文獻: 標(biāo)題:Epigenetic modifications of Nrf2-mediated glutamate-cysteine ligase: implications for the development of diabetic retinopathy and the metabolic memory phenomenon associated with its continued progression.作者:Mishra M, Zhong Q, Kowluru RA;雜志名稱:Free Radic Biol Med 標(biāo)題:Prenatal Iron Deficiency and Choline Supplementation Interact to Epigenetically Regulate Jarid1b and Bdnf in the Rat Hippocampus into Adulthood作者:Liu, S. et. al.;雜志名稱:Nutrients 標(biāo)題:H(2)S Alleviates Neuropathic Pain in Mice by Nrf2 Signaling Pathway Activation.作者:Wang J, Zhang N, Liu HZ, Wang JL, Zhang YB, Su DD, Miao J;雜志名稱:J Mol Neurosci Epigentek 公司是全球領(lǐng)先的表觀遺傳學(xué)相關(guān)研究的技術(shù)創(chuàng)新者和產(chǎn)品開發(fā)供應(yīng)商。開發(fā)了超過700多個專利產(chǎn)品,為表觀遺傳學(xué)方面的研究和新藥研發(fā)提供全面系統(tǒng)的解決方案,涵蓋樣品制備、DNA/RNA甲基化(5-mc, 5-hmc, 5-fc, m6A)/DNMT分析、ChIP、組蛋白甲基化/乙酰化/去乙酰化/磷酸化/SUMO-等領(lǐng)域,提供小分子抑制劑、蛋白質(zhì)、抗體、以及分析試劑盒產(chǎn)品。